AuntMinnieEurope.com Molecular Imaging Insider

Dear Molecular Imaging Insider,

Any European research that's published in the highly regarded U.S. journal Radiology is always worth a close look, so I'm sure you'll want to read about a new study from Munich involving the use of PET/CT for detecting the recurrence of neuroendocrine tumors. To read more, go to your Molecular Imaging Digital Community, or click here.

Other molecular imaging research from Munich also has caught our eye. A group from the department of radiology at the city's Technical University conducted a detailed comparison between PET/MRI and PET/CT in terms of its ability to diagnose malignant bone lesions. Get the story here.

Meanwhile, a team from the University of Tübingen, Germany, has evaluated the quantification accuracy, homogeneity, and stability of two PET/MRI systems in the brain. The prime goal was to test whether existing PET/MR systems based on avalanche photodiodes technology can perform dynamic PET scans using short half-life radiotracers, such as cerebral blood flow studies with oxygen-15-labeled water. Click here to learn more.

Interpretation of MRI findings after radiation therapy of head and neck cancers constitutes a diagnostic challenge, according to prize-winning researchers from Geneva. They have found that diffusion-weighted imaging and PET/MRI can increase diagnostic confidence for detecting recurrent tumors and help avoid unnecessary biopsies. To find out more, click here.

Last but not least, a group from Essen, Germany, has concluded that simultaneous PET/MRI for patients with acute myocardial infarction is feasible after finding "good concordance" in a comparison of PET and MR images. Click here for the full details.

This is only a small selection of articles that have appeared over recent weeks in your Molecular Imaging Digital Community. The full list appears below this letter.

Page 1 of 117
Next Page